St. Jude revisits RESPECT trial, touts signs of benefits of Amplatzer device
February 8, 2013 by MassDevice staff
St. Jude Medical touts new findings from its failed RESPECT trial, reporting that the Amplatzer PFO closure device demonstrated benefits over drug therapy alone.
Medical device giant St. Jude Medical (NYSE:STJ) resurrected data from its failed RESPECT study, touting additional analyses and benefits of its Amplatzer patent foramen ovale closure device.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
Navigation
NEWS
Claret Medical's filter thwarts debris headed for the brain in TAVI patients, study shows
California medical device maker Claret Medical's embolic protection technology captures debris...
Report: Galt Medical's Texas plant closure means 139 layoffs
Texas-based Galt Medical Corp. is reportedly laying off 139 workers as it shutters its hometown plant...
FLASH: Medtronic's Q4, 2013 profits slide
Medtronic's fiscal 4th-quarter and 2013 profits slide on low-single-digit revenue growth, but the...
Wound Management Technologies settles tax liability
Wound Management Technologies strikes a deal with the IRS to settle payroll tax liabilities and...
Healthcare reform will help lower the federal deficit, CBO says | MassDevice.com On Call
The Congressional Budget Office says that healthcare reform and other proposals in the White House's...
